Related Experiment Video
Updated: Oct 5, 2026

Induction and Assessment of Exertional Skeletal Muscle Damage in Humans
Published on: December 11, 2016
Direct determination of distribution volume and disappearance rate of native creatine kinase in humans
Insights
This study characterizes creatine kinase (CK) distribution volume and disappearance rate in humans after myocardial infarction. A one-compartment model is suitable for clinical use, as true disappearance rate cannot be determined post-infarction.
Area of Science:
- Biochemistry
- Cardiology
- Pharmacokinetics
Background:
- Accurate estimation of myocardial infarct size requires characterizing creatine kinase (CK) distribution volume (DV) and disappearance rate (Kd).
- Existing human values for CK DV and Kd are extrapolated from experimental models.
- These parameters are crucial for enzymatic assessment of infarct size.
Purpose of the Study:
- To characterize the distribution volume (DV) and disappearance rate (Kd) of native creatine kinase (CK) in human patients with acute myocardial infarction.
- To determine if a one-compartment model is suitable for clinical application of CK parameters.
- To investigate the correlation between CK Kd estimated post-infarction and calculated after reinfused plasma.
Main Methods:
- Collected enzyme-rich plasma from 10 acute myocardial infarction patients during hemodynamic monitoring.
- Reinfused plasma after CK serum activity returned to baseline and collected blood samples over 12 hours.
- Analyzed total CK, MM-CK, and MB-CK concentrations using spectrophotometry and radioimmunoassay, with data analyzed via nonlinear least-squares approximation or noncompartmental approach.
Main Results:
- Concentrations of immunologically active CK molecules declined in parallel to enzymatic activity.
- A single exponential decay was observed in most patients, yielding a Kd of 0.0023 +/- 0.00057 min⁻¹.
- The average DV was 3284 +/- 693 ml (5% of body weight), and no correlation was found between pre- and post-reinfusion Kd estimates.
Conclusions:
- A one-compartment model utilizing CK Kd and DV values compatible with plasma volume is suitable for clinical use.
- The true CK disappearance rate (Kd) cannot be accurately determined from the terminal portion of CK time-activity curves following acute infarction.
- This study provides essential pharmacokinetic data for creatine kinase in myocardial infarction patients.
Abstract:
Distribution volume (DV) and disappearance rate (Kd) of native creatine kinase (CK), parameters needed for enzymatic estimation of infarct size, have not been characterized in humans. Values for these parameters have been determined in experimental models and extrapolated for use in humans. During hemodynamic monitoring, 100 to 150 ml of enzyme-rich plasma was collected from 10 patients with acute myocardial infarction, stored at -30 degrees C for a maximum of 6 days, and then rapidly reinfused back to the same patient after return of CK serum activity to baseline levels. After reinfusion, blood samples were obtained at 5- to 15-minute intervals for 2 hours and at 30- to 60-minute intervals for an additional 10 hours. In each specimen, total CK activity and MM-CK and MB-CK concentrations were determined by spectrophotometry and radioimmunoassay. Data were analyzed by either nonlinear least-squares approximation or the noncompartmental approach after baseline subtraction. Concentration of immunologically active molecules appeared to decline in parallel to enzymatic activity. In three patients a double exponential decay was demonstrated. All others exhibited single exponential decay, with a Kd of 0.0023 +/- 0.00057 (SD) min-1. DV averaged 3284 +/- 693 (SD) ml, 5% of body weight. There was no correlation between Kd estimated from terminal portions of CK time-activity curves following infarction and Kd calculated after reinfused plasma. It was concluded that a one-compartment model using values for Kd and a DV compatible with plasma volume is suitable for clinical application, and that true Kd cannot be determined from the terminal portion of CK time-activity curves after acute infarction.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:01Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Related Concept Videos
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
One-Compartment Open Model: Urinary Excretion Data and Determination of k
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration